IDDF2020-ABS-0015 Prucalopride in the treatment of chronic GERD
IDDF2020-ABS-0015 Prucalopride in the treatment of chronic GERD
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
BackgroundTreatment of persistence of gastroesophageal reflux disease (GERD) symptoms, despite readily available medications and lifestyle advocation is challenging. Prucalopride, a selective high-affinity serotonin (5-HT4) receptor agonist, has been a good therapeutic alternative. Data from large randomized, controlled clinical trials indicate tha...
Alternative Titles
Full title
IDDF2020-ABS-0015 Prucalopride in the treatment of chronic GERD
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2461837344
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2461837344
Other Identifiers
ISSN
0017-5749
E-ISSN
1468-3288
DOI
10.1136/gutjnl-2020-IDDF.42
